ACLX FY 2019 Earnings — Arcellx, Inc. Revenue & Financial Results | Market Cap Arena

ACLXArcellx, Inc.

$7B

FY 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$326,000

Operating Income

-$18M

Net Income

-$18M

EPS (Diluted)

$-0.52

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$23M

Stock-Based Comp.

$136,000

Balance Sheet

Total Assets

$44M

Total Liabilities

$76M

Stockholders' Equity

-$33M

Cash & Equivalents

$35M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$326,000	$0	—
Operating Income	-$18M	-$8M	-116.3%
Net Income	-$18M	-$8M	-116.3%